Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events
Pfizer, Sarepta team with fellow DMD gene therapy makers to [...]
FDA has change of heart, plans to convene advisory meeting for Cytokinetics’ cardiac med
FDA has change of heart, plans to convene advisory meeting [...]
Ampio’s years of troubles come to a head with internal investigation, trio of COVID trial failures
Ampio’s years of troubles come to a head with internal [...]
After 14 years, Agios is looking for a partner to tango with, but tough changes lie ahead
After 14 years, Agios is looking for a partner to [...]
VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions
VC firm Sofinnova banks $1B from Apollo to invest in [...]
AbbVie coughs up nearly $50M for Cugene’s autoimmune med in a bid to shore up life post-Humira
AbbVie coughs up nearly $50M for Cugene’s autoimmune med in [...]
Update: Checkmate details bleak future if $250M Regeneron merger does not close
Update: Checkmate details bleak future if $250M Regeneron merger does [...]
Adagio still hopes to build omicron offense for lead COVID-19 therapy
Adagio still hopes to build omicron offense for lead COVID-19 [...]
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal
BridgeBio adds another $110M to coffers with voucher sale a [...]
FDA tags Editas’ thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic
FDA tags Editas’ thalassemia cell therapy an orphan drug as [...]